EFG Asset Management (Americas)’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-913
| Closed | -$302K | – | 139 |
|
|
2022
Q1 | $302K | Sell |
913
-130
| -12% | -$43K | 0.06% | 123 |
|
|
2021
Q4 | $375K | Buy |
1,043
+14
| +1% | +$5.03K | 0.06% | 122 |
|
|
2021
Q3 | $335K | Sell |
1,029
-3
| -0.3% | -$977 | 0.06% | 125 |
|
|
2021
Q2 | $322K | Buy |
1,032
+149
| +17% | +$46.5K | 0.06% | 129 |
|
|
2021
Q1 | $281K | Buy |
883
+78
| +10% | +$24.8K | 0.06% | 128 |
|
|
2020
Q4 | $261K | Sell |
805
-26
| -3% | -$8.43K | 0.05% | 128 |
|
|
2020
Q3 | $230K | Buy |
+831
| New | +$230K | 0.05% | 130 |
|
|
2019
Q4 | – | Sell |
-10,034
| Closed | -$1.79M | – | 127 |
|
|
2019
Q3 | $1.79M | Sell |
10,034
-2
| -0% | -$356 | 0.54% | 67 |
|
|
2019
Q2 | $2.61M | Buy |
10,036
+880
| +10% | +$229K | 0.74% | 61 |
|
|
2019
Q1 | $2.62M | Buy |
9,156
+696
| +8% | +$199K | 0.79% | 55 |
|
|
2018
Q4 | $2.75M | Buy |
8,460
+902
| +12% | +$293K | 0.99% | 43 |
|
|
2018
Q3 | $3.4M | Buy |
7,558
+3,400
| +82% | +$1.53M | 0.97% | 38 |
|
|
2018
Q2 | $1.7M | Buy |
4,158
+1,982
| +91% | +$811K | 0.51% | 63 |
|
|
2018
Q1 | $633K | Buy |
+2,176
| New | +$633K | 0.26% | 81 |
|